NEW YORK (GenomeWeb) – Foundation Medicine today reported a 70 percent increase in preliminary revenues for the fourth quarter.

For the quarter ended Dec. 31, preliminary unaudited revenues totaled $48.9 million, up from $28.8 million during the year-ago quarter. Analysts, on average, had estimated Q4 revenues to be only $39.2 million. Expected revenues from biopharmaceutical companies are $33.4 million, up from $19 million in Q4 of 2016, and expected revenues from clinical testing are $15.5 million, up from $9.8 million during last year's fourth quarter.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

 Senator Lamar Alexander (R-Tenn.), who chairs the Senate health committee, will be retiring at the end of his term, Stat News reports.

UCSF researchers find that having two X chromosomes may contribute to women's longer lifespans, according to Discover's D-brief blog.

The Wall Street Journal reports on the US Centers for Disease Control and Prevention's use of genetic approaches to study foodborne illnesses.

In PNAS this week: immune cell profiling of wild baboons by social status, metabolomics profiling of esophageal tumors, and more.

Jan
30
Sponsored by
Loop Genomics

This webinar will provide a comparison of several next-generation sequencing (NGS) approaches — including short-read 16S, whole-genome sequencing (WGS), and synthetic long-read sequencing technology — for use in microbiome research studies.